These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 28431518)
1. Is adjuvant chemotherapy necessary in pT1N1 gastric cancer? Shin HB; An JY; Lee SH; Choi YY; Kim JW; Sohn SS; Noh SH BMC Cancer; 2017 Apr; 17(1):287. PubMed ID: 28431518 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant Chemotherapy Versus Chemoradiotherapy Versus Surgery Alone for Early Gastric Cancer with One or Two Lymph Node Metastasis. Kim SM; An JY; Lee J; Sohn TS; Kim S Ann Surg Oncol; 2018 Jun; 25(6):1616-1624. PubMed ID: 29569127 [TBL] [Abstract][Full Text] [Related]
3. Microsatellite Instability and Effectiveness of Adjuvant Treatment in pT1N1 Gastric Cancer: A Multicohort Study. Oh N; Kim H; Kim KM; Cheong JH; Lee J; Noh SH; Sohn TS; Choi YY; An JY Ann Surg Oncol; 2021 Dec; 28(13):8908-8915. PubMed ID: 34401986 [TBL] [Abstract][Full Text] [Related]
4. Changing patterns of prognosticators during 15-year follow-up of advanced gastric cancer after radical gastrectomy and adjuvant chemotherapy: a 15-year follow-up study at a single korean institute. Moon YW; Jeung HC; Rha SY; Yoo NC; Roh JK; Noh SH; Kim BS; Chung HC Ann Surg Oncol; 2007 Oct; 14(10):2730-7. PubMed ID: 17632757 [TBL] [Abstract][Full Text] [Related]
5. The patterns and timing of recurrence after curative resection for gastric cancer in China. Liu D; Lu M; Li J; Yang Z; Feng Q; Zhou M; Zhang Z; Shen L World J Surg Oncol; 2016 Dec; 14(1):305. PubMed ID: 27931221 [TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy for elderly patients (aged 70 or older) with gastric cancer after a gastrectomy with D2 dissection: A single center experience in Korea. Jo JC; Baek JH; Koh SJ; Kim H; Min YJ; Lee BU; Kim BG; Jeong ID; Cho HR; Kim GY Asia Pac J Clin Oncol; 2015 Dec; 11(4):282-7. PubMed ID: 25856172 [TBL] [Abstract][Full Text] [Related]
7. Chemoresponse after non-curative gastrectomy for M1 gastric cancer. Shin HB; Lee SH; Son YG; Ryu SW; Sohn SS World J Surg Oncol; 2015 Jan; 13():13. PubMed ID: 25634223 [TBL] [Abstract][Full Text] [Related]
8. Risk factors for peritoneal recurrence in stage II/III gastric cancer patients who received S-1 adjuvant chemotherapy after D2 gastrectomy. Aoyama T; Yoshikawa T; Hayashi T; Kuwabara H; Mikayama Y; Ogata T; Cho H; Tsuburaya A Ann Surg Oncol; 2012 May; 19(5):1568-74. PubMed ID: 22143578 [TBL] [Abstract][Full Text] [Related]
9. Factors associated with early recurrence after curative surgery for gastric cancer. Kang WM; Meng QB; Yu JC; Ma ZQ; Li ZT World J Gastroenterol; 2015 May; 21(19):5934-40. PubMed ID: 26019458 [TBL] [Abstract][Full Text] [Related]
10. Gastrectomy in comprehensive treatment of advanced gastric cancer with synchronous liver metastasis: a prospectively comparative study. Li Z; Fan B; Shan F; Tang L; Bu Z; Wu A; Zhang L; Wu X; Zong X; Li S; Ren H; Ji J World J Surg Oncol; 2015 Jul; 13():212. PubMed ID: 26126412 [TBL] [Abstract][Full Text] [Related]
11. Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer: A propensity score matching analysis. Kanda M; Murotani K; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y Surgery; 2015 Dec; 158(6):1573-80. PubMed ID: 26120068 [TBL] [Abstract][Full Text] [Related]
12. A phase II study of adjuvant S-1/cisplatin chemotherapy followed by S-1-based chemoradiotherapy for D2-resected gastric cancer. Shim HJ; Kim KR; Hwang JE; Bae WK; Ryu SY; Park YK; Nam TK; Chung IJ; Cho SH Cancer Chemother Pharmacol; 2016 Mar; 77(3):605-12. PubMed ID: 26846507 [TBL] [Abstract][Full Text] [Related]
13. Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer. Chipponi J; Huguier M; Pezet D; Basso N; Hay JM; Quandalle P; Jaeck D; Fagniez PL; Gainant A Am J Surg; 2004 Mar; 187(3):440-5. PubMed ID: 15006580 [TBL] [Abstract][Full Text] [Related]
14. Changes in postoperative recurrence and prognostic risk factors for patients with gastric cancer who underwent curative gastric resection during different time periods. Kim DH; Kim SM; Hyun JK; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S Ann Surg Oncol; 2013 Jul; 20(7):2317-27. PubMed ID: 23677605 [TBL] [Abstract][Full Text] [Related]
15. Adjuvant capecitabine plus oxaliplatin after D2 gastrectomy in Japanese patients with gastric cancer: a phase II study. Fuse N; Bando H; Chin K; Ito S; Yoshikawa T; Tsuburaya A; Terashima M; Kawashima Y; Fukunaga T; Gotoh M; Emi Y; Yoshida K; Oki E; Takahashi S; Kuriki H; Sato K; Sasako M Gastric Cancer; 2017 Mar; 20(2):332-340. PubMed ID: 26956689 [TBL] [Abstract][Full Text] [Related]
16. Adjuvant Chemotherapy vs. Surgery Alone for pT3N0M0 Gastric Cancer. Kang M; Youn HG; An JY; Choi MG; Lee JH; Sohn TS; Bae JM; Kim S Ann Surg Oncol; 2021 Mar; 28(3):1437-1444. PubMed ID: 33078315 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy with 5-fluorouracil, doxorubicin and mitomycin-C (FAM) for 6 months after curative resection of gastric carcinoma. Koo DH; Lee JL; Kim TW; Chang HM; Ryu MH; Yook JH; Oh ST; Kim BS; Lee JS; Kang YK Eur J Surg Oncol; 2007 Sep; 33(7):843-8. PubMed ID: 17207959 [TBL] [Abstract][Full Text] [Related]
18. Early postoperative intraperitoneal chemotherapy with mitomycin C, 5-fluorouracil and cisplatin for advanced gastric cancer. Noh SH; Yoo CH; Chung HC; Roh JK; Shin DW; Min JS Oncology; 2001; 60(1):24-30. PubMed ID: 11150904 [TBL] [Abstract][Full Text] [Related]
19. Efficiency of adjuvant immunochemotherapy following curative resection in patients with locally advanced gastric cancer. Popiela T; Kulig J; Czupryna A; Szczepanik AM; Zembala M Gastric Cancer; 2004; 7(4):240-5. PubMed ID: 15616772 [TBL] [Abstract][Full Text] [Related]
20. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]